health – Page 5 – Market Industry Forecast News

Hydrogel-based Drug Delivery System Market Key Insights: Navigating Emerging Trends

The global hydrogel-based drug delivery system market size is anticipated to reach USD 11.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2024 to 2030. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.

Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.

Access the Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Delivery Route, By Region, And Segment Forecast, 2024 – 2030

The unique physical properties of hydrogel attract their interest in use for drug delivery applications. The porosity and drug loading capacity of hydrogels can be adjusted by modifying the density of cross-linking. This helps them to protect liable large drug molecules from degradation increasing the half-life. Many research studies have been carried out to examining the delivery of insulin orally using hydrogel systems. As patient compliance issues are frequently reported with injectable insulins such innovation is expected to be a disruptive technology in the diabetes care market.

There are numerous clinical studies underway specific to hydrogel-based drug delivery systems and various hydrogel technologies have already received regulatory approval for biomedical application. However, the technological challenges including the absence of defined regulatory guidelines, chemistry, complex manufacturing and control paraments, and practical adaptability are major roadblocks in the successful implementation in drug delivery use. For instance, the fabrication of hydrogel is complex and varies significantly depending upon the hydrogel systems.

Hydrogel-based Drug Delivery System Market Report Highlights

Based on polymer origin, the synthetic segment held the largest proportion of market share in 2023

The hybrid segment is expected to witness the fastest growth rate over the forecast period owing to the development of stimuli-responsive hydrogel technology

The synthetic segment is anticipated to grow fast over the forecast period compared to natural hydrogels due to their high drug loading capacity and improved mechanical strength

Based on delivery route, the ocular segment accounted for the largest revenue share in 2023

The subcutaneous segment is expected to grow at a healthy rate over the forecast period owing to the increasing number of clinical and pre-clinical studies carried out

North America holds the largest revenue share in this market due to the presence of key companies in the region doing R&D on specific hydrogel-based drug delivery systems

In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to large patient base, improving healthcare infrastructure, and surging demand for modern therapies

Order your free sample copy of “Hydrogel-based Drug Delivery System Market Report 2024 – 2030, published by Grand View Research

Key Hydrogel-based Drug Based Delivery System Company Insights

Some key companies in the market include GALDERMA; Blairex Laboratories, Inc.; Johnson & Johnson; Bausch + Lomb; Medtronic; and Ocular Therapeutix, Inc. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other emerging and prominent industry participants.

Ocular Therapeutix, Inc., is a biopharmaceutical company that specializes in creating, advancing, and marketing new treatments for eye disorders. It employs its own bioresorbable hydrogel-based formulation technology, ELUTYX. The company has manufacturing facilities in Massachusetts.

Blairex Laboratories, Inc., a global pharmaceutical company, delivers products related to the consumer and pharmaceutical industry. Some of the company’s major offerings are sterile saline solutions and contact lens care.

Key Hydrogel-based Drug Delivery System Companies:

The following are the leading companies in the hydrogel-based drug delivery system market. These companies collectively hold the largest market share and dictate industry trends.

GALDERMA
Blairex Laboratories, Inc
Johnson & Johnson
Bausch + Lomb.
Medtronic
Ocular Therapeutix, Inc.
Ferring B.V.
Endo, Inc.
Tolmar Inc

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Military Wearable Medical Devices Market Key Insights: Navigating Emerging Trends

The global military wearable medical devices market size is expected to reach USD 38.77 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 26.3% from 2024 to 2030. The growth of the market is attributed to the improvement in the overall performance of military soldiers with the help of innovative technology and the rising demand for lightweight military devices.

The Covid-19 pandemic has transformed the market for military wearable medical devices because wearable technologies could monitor, detect, and prevent the spread of the virus. The Covid-19 virus has indirectly increased the demand for wearable medical devices. According to the WHO guidelines, viral infection mainly spreads through the eyes, nose, and mouth and it is difficult to identify the virus during the initial days of contract. Hence, with the innovative technology, the individual can regularly check and monitor their body temperature, oxygen level, heart rate, and body performance so that if they found any negative result, then they can immediately take precautions and treatment.

Access the Military Wearable Medical Devices Market Size, Share & Trends Analysis Report By Application (Heart, Performance Monitor), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2024 – 2030

As soldiers have to train and work in a rough and harsh environment, the wearable device they are carrying must be lightweight and must provide full information of the soldier’s health and performance. Many market players are developing and introducing such wearable devices, which can bear the toughest environment of the battlefield. With the help of the device, armed forces can track and monitor the sleep of every individual, circadian stability, and all physical activity so that they can make necessary changes for better results as per the data.

As per the soldier modernization program, the military has decided to opt for lightweight wearable devices as soldiers already have to carry heavy stuff with them and such devices can increase the speed of the movement. The devices should be easy to carry and made of the toughest material to adapt to the environment. These devices should result in the betterment of the overall performance of the individuals.

Military Wearable Medical Devices Market Highlights

By application, the heart monitor segment held the largest revenue share in 2023 as the system directly detects any uncertain change in the health of an individual, and the patient can be treated as early as possible

North America led the market in 2023 and is expected to maintain its lead over the forecast period owing to technological advancements and increasing R&D investment in military devices

Asia Pacific is expected to witness the fastest growth over the forecast period due to the rising cardiovascular events in the region and rising healthcare spending

The industry is highly competitive with players who are developing advanced medical devices for the soldiers that can be used in war zones or in extreme environments

Order your free sample copy of “Military Wearable Medical Devices Market Report 2024 – 2030, published by Grand View Research

Key Military Wearable Medical Devices Company Insights

Some key companies in the market include Samsung, Bittium, Garmin, Apple Inc., Fitbit, and GOQii. Companies are focusing on longer battery life, connectivity, and accurate readings in the devices.

Garmin has been deploying products in segments such as automotive, marine, aviation, sports & outdoor with a focus on rugged use and long battery life providing a wide range of services through their devices such asMulti-GNSS Support, ABC sensors, trackback routing, geocaching, point-to-point navigation, compass, GPS compass.

Apple Inc. monitors heart rates, fall detection, blood oxygen level, and AFib history with the help of an electrical heart sensor in their product.

Key Military Wearable Medical Devices Companies:

The following are the leading companies in the military wearable medical devices market. These companies collectively hold the largest market share and dictate industry trends.

Bittium
Polar Electro
Oura
Garmin
NeuroMetrix
GOQii
Apple Inc.
Samsung
Fitbit
Zephyr Technology Corporation
Camntec

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Buttock Augmentation Market Key Insights: Navigating Emerging Trends

The global buttock augmentation market size is anticipated to reach USD 11.72 billion by 2030, according to the new report of Grand View Research, Inc. The market is expected to expand at a CAGR of 21.5% from 2024 to 2030. Buttock augmentation also called gluteal augmentation is a technique used to contour, size, and enhance the appearance. A buttock lift is reported to improve the tone of the underlying tissue and is mainly done by using implants, fat grafting, or sometimes a combination of the two.

Factors like rising technological advancement in aesthetics, rising disposable income, increasing aesthetic consciousness and the high success rate of augmentation procedures are propelling the market growth. According to the International Society of Aesthetic Plastic Surgery, around 5, 34,345 butt augmentation and lift procedures were carried out globally in 2019. Buttock augmentation accounts for 4.7% of total surgical procedures globally.

Access the Buttock Augmentation Market Size, Share & Trends Analysis Report By Procedure (Buttock Implants, Buttock Injections), By End-use (Hospitals, Aesthetic Clinics), By Region, And Segment Forecasts, 2024 – 2030

Growing social media influence, high consciousness towards aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the reasons for market growth. In the light of COVID-19, the market was hampered as patient appointments for surgical treatments were temporarily suspended. However, since the government in many countries has allowed resuming elective surgical procedures, clinics have also started buttock lift and grafting procedures again. Moreover, according to the BBC network, inquiries and appointments for many surgical and non-surgical cosmetic treatments have seen a surge following the pandemic and are thus expected to propel market growth.

Buttock Augmentation Market Report Highlights

By procedure, the buttock implant procedure segment held the largest revenue share in 2023 as techniques like fat grafting and butt lift are more in demand and has faster post-operative healing

Based on implant type, the fat grafting segment accounted for the largest revenue share in 2023 as this procedure is less complicated, takes less operative time, and has more success rate

In North America, the market accounted for the largest revenue share in 2023 as the region has a high awareness of such procedure and there is high availability of aesthetic professionals

In Asia Pacific, the market is expected to grow significantly in the forecast period owing to technological advancements and an increase in patients opting for procedures to improve aesthetic appearances

Order your free sample copy of “Buttock Augmentation Market Report 2024 – 2030, published by Grand View Research

Key Buttock Augmentation Company Insights

Some of the companies key companies in global buttock augmentation market are Abbvie (AllerganAesthetics), GC Aesthetics, Sebbin, and other. To develop a competitive edge over others, the key companies have embraced strategies such as innovation.

Allergan Aesthetics, a subsidiary of the global pharmaceutical organization AbbiVie, develops, manufactures, and distributes offerings related to body contouring, facial injectables, skin care, and plastics. The company also invests heavily in research and development activities to deliver innovation-backed products. It is headquartered in Irvine, California, and has several manufacturing sites across multiple locations around the world.

GC Aesthetics, one of the prominent players in aesthetic enhancements and pre & post-surgery solutions, primarily delivers offerings related to breast enhancements, face implants, body implants, and Remote Valve Tissue Expanders (RVTEs).

Key Buttock Augmentation Companies:

The following are the leading companies in the buttock augmentation market. These companies collectively hold the largest market share and dictate industry trends.

Abbvie. (AllerganAesthetics)
Dermax Co. Ltd.
GC Aesthetics
Implantech
Sientra Inc.
Sebbin
Merz Pharma
Alpha Aesthetics
Hanson Medical Inc.
GALDERMA 2024
CGBio

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Polynucleotides Injectable Market Drivers: Surge in Cosmetic Enhancements

The global polynucleotides injectable market size is expected to reach USD 293.4 million by 2030, and is projected to grow at a CAGR of 14.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The technological advancements in the biotechnology sector primarily drive the market growth. The increasing demand for personalized medicine, skin rejuvenation, and investments in R&D are also major factors for market growth.

The global population’s growing interest in minimally invasive cosmetic treatments has led to a surge in demand for alternatives to surgical interventions. Polynucleotide injectables offer a non-invasive way to regenerate the skin and address age-related issues, favoring their popularity in the medical aesthetics industry. With the global population steadily aging, there is a heightened demand for products and treatments that can combat the visible signs of aging. Polynucleotide injectables provide a natural and effective solution for reducing fine lines, wrinkles, and sagging skin while promoting long-term skin health.

The report “Polynucleotides Injectable Market Size, Share & Trends Analysis Report By Application (Eyes, Lips), By End-use (MedSpas, Aesthetic & Cosmetic Centers), By Region, and Segment Forecasts, 2024 – 2030” is available now to Grand View Research customers and can also be purchased directly

Continuous innovations in regional regenerative medicine are unlocking new therapeutic applications for polynucleotide injectables. These advertisements not only expand their use in cosmetic procedures but also open up new possibilities for treating a variety of conditions, such as joint damage, tendonitis, and ligament injuries. Consumers are becoming more informed about the safety and efficacy of treatments. Polynucleotides are naturally derived and are considered safe with a low risk of allergic reactions or complications, making them an attractive option for patients seeking safe nonsynthetic solutions.

The potential for expansion into new therapeutic areas presents substantial opportunities. Beyond cosmetic treatments, the use of polynucleotide injectables in orthopedic conditions, chronic wounds, and tissue regeneration offers an untapped market with significant growth potential. As clinical studies continue to demonstrate the efficacy of polynucleotides in a broader range of applications, the market is poised for accelerated growth.

Polynucleotides Injectable Market Report Highlights:

Based on application, the eye segment held the largest revenue share of 63.9% in 2023. This large share is driven by the growing demand for non-invasive solutions to address various eye-related concerns. Polynucleotide injectables improve the appearance of fine lines, wrinkles, and skin laxity around the delicate eye area, which is often a key concern for aging individuals.
In terms of end use, the MedSpas segment held the largest revenue share of 50.1% in the polynucleotide injectable market, driven by consumers’ growing demand for non-invasive aesthetic treatments. Polynucleotides’ unique properties, which enable them to stimulate collagen production, enhance skin texture, and diminish the appearance of fine lines and wrinkles, have made these injectable treatments a highly sought-after option among MedSpa clients seeking natural and long-lasting aesthetic improvements.
The Asia Pacific polynucleotide market held the largest global revenue share of 50.5% in 2023 as the region is witnessing several key trends, including the emergence of domestic players offering low-cost products to expand market access and affordability.

Order your free sample copy of “Polynucleotides Injectable Market Report 2024 – 2030, published by Grand View Research

Polynucleotides Injectable Market Segmentation

Grand View Research has segmented the global polynucleotides injectable market based on application, end use, and region:

Polynucleotides Injectable Application Outlook (Revenue, USD Million, 2018 – 2030)
- Eyes
- Lips
- Forehead
- Jawline & Cheekbones
- Others
Polynucleotides Injectable End Use Outlook (Revenue, USD Million, 2018 – 2030)
- MedSpas
- Aesthetic & Cosmetic Centers
- Hospitals
Polynucleotides Injectable Regional Outlook (Revenue, USD Million, 2018 – 2030)
- North America
- - U.S.
- - Canada
- - Mexico
- Europe
- - UK
- - Germany
- - France
- - Italy
- - Spain
- - Denmark
- - Sweden
- - Norway
- Asia Pacific
- - Japan
- - China
- - India
- - Australia
- - South Korea
- - Thailand
- Latin America
- - Brazil
- - Argentina
- Middle East and Africa
- - South Africa
- - Saudi Arabia
- - UAE
- - Kuwait

List of Key Players in the Polynucleotides Injectable Market

PHARMA RESEARCH
BIOPLUS CO., LTD.
LG Chem
AMEELA
Mastelli
Pluryal
Promoitalia Laboratories.
Fox Pharma
BR Pharm
DermaFocus

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Dental Implants Market: Innovations in Materials and Techniques Transforming Care

The global dental implants market size is expected to reach USD 9.62 billion by 2030, registering a CAGR of 9.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising demand for tooth replacement has provided good growth potential to the market. The increasing number of dental injuries owing to road accidents and sports injuries are some of the major factors boosting the market growth.

With growing aesthetic awareness, people are exploring more treatment options, which is leading to the growth of the market. For instance, as per the American Academy of Cosmetic Dentistry data, more than 95.0% of individuals across the globe believe that their smile is a vital social asset and nearly 84.0% revealed to be under increased pressure to perfect their smile, thus increasing the product demand. Dental implants are considered the only restorative technique that preserves and stimulates natural bone. Owing to the growing number of edentulous people, the demand for prosthetics is increasing, which is expected to be one of the major impact-rendering drivers for the market.

Access the Dental Implants Market Size, Share & Trends Analysis Report By Implant Type (Zirconium, Titanium), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2024 – 2030

Several industries have halted their services due to the COVID-19 pandemic. However, the dental care industry is greatly impacted by the significant decrease in elective procedures, many of which are being postponed or canceled so that hospitals can focus their resources on treating patients with COVID-19. Major Countries like the U.S and India procure raw materials and electronic components from China, which has disrupted the supply chain of many dental equipments and product manufacturers. However, with the decrease in the number of COVID-19 cases, hospitals are likely to begin scheduling elective procedures, depending on their capacity of admission and patients comfort level.

Dental Implants Market Report Highlights

The titanium segment held the largest share of more than 91.36% of the overall revenue in 2023 due to its wide applications, durability, and cost-effectiveness

The zirconium segment is anticipated to be the fastest-growing product segment over the forecast period due to better flexural strength, improved aesthetic appearance, and less corrosiveness as compared to titanium

North America dominated the global dental implants market and accounted for the maximum share of more than 35.64% in 2023 owing to high awareness about restorative treatments and the presence of established market players

Order your free sample copy of “Dental Implants Market Report 2024 – 2030, published by Grand View Research

Key Companies & Market Share Insights

Companies are focusing on strategic initiatives, such as the introduction of novel products through customization according to consumers’ needs, partnerships, collaborations, and mergers & acquisitions, to expand their product portfolio and extend leadership positions in the field of dental implantology. Moreover, the competition between key players will turn intense in the coming years as they are focusing more on geographical expansion, strategic collaborations, and partnerships through mergers & acquisitions. In May 2020, Straumann Group announced a new zygomatic implant solution for patients with severe jawbone loss in collaboration with Southern Implants. The new solution combines proven implant design features with the advantages of Straumann’s BLX and BLT implant prosthetic range.

Key Dental Implants Companies:

BioHorizons IPH, Inc.
Nobel Biocare Services AG
Zimmer Biomet Holdings, Inc.
OSSTEM IMPLANT
Institut Straumann AG
Bicon, LLC
Leader Italy
Anthogyr SAS
DENTIS
DENTSPLY Sirona
DENTIUM Co., Ltd.
T-Plus Implant Tech. Co.
KYOCERA Medical Corp.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Innovations in Antimicrobial Additives Enhance Hygiene and Safeguard Public Health

Antimicrobial additives have emerged as a crucial technology in consumer products and industrial applications. These additives are designed to inhibit the growth of microorganisms on various surfaces, thereby enhancing product longevity, hygiene standards, and overall safety. As the demand for antimicrobial protection continues to rise across sectors such as healthcare, packaging, textiles, and food processing, the global antimicrobial additives market is experiencing significant growth and evolution.

Antimicrobial additives are substances infused into materials during manufacturing to prevent the growth of bacteria, fungi, algae, and other microbes. They work by disrupting the cellular processes of microorganisms, thereby inhibiting their growth and reproduction. Common antimicrobial agents used in these additives include silver ions, copper ions, zinc pyrithione, quaternary ammonium compounds (QACs), and triclosan, among others.

Access the Antimicrobial Additives Market Size, Share & Trends Analysis Report 2024-2030, published by Grand View Research

Market Drivers

Increasing awareness about the importance of cleanliness and hygiene, especially in healthcare settings and public places, is a significant driver of the antimicrobial additives market. Consumers are more conscious about the transmission of infections and are seeking products that offer antimicrobial protection. Hospitals, clinics, and other healthcare facilities require stringent infection control measures. Antimicrobial additives in medical devices, equipment, and surfaces help in reducing the risk of healthcare-associated infections (HAIs).

In the consumer goods sector, antimicrobial additives are incorporated into products such as textiles, household appliances, and personal care items. The desire for products that stay cleaner and fresher for longer periods is boosting the demand for antimicrobial-treated goods.

Regulatory bodies across the globe are increasingly emphasizing hygiene and safety standards in various industries. This regulatory support encourages manufacturers to incorporate antimicrobial additives into their products to meet compliance requirements.

Challenges of the Antimicrobial Additives Market

Environmental concern is the biggest challenge in the market for antimicrobial additives. Some antimicrobial additives, such as triclosan, have faced scrutiny due to their potential environmental impact and health concerns. Regulatory restrictions and consumer preferences for eco-friendly alternatives pose challenges to the market growth of certain antimicrobial agents.

There is ongoing concern about the development of antimicrobial resistance among microorganisms when exposed to antimicrobial agents over time. This necessitates continuous research and development efforts to innovate new antimicrobial technologies. Moreover, the incorporation of antimicrobial additives can add to the production costs of materials and products. Manufacturers need to balance the benefits of antimicrobial protection with cost-effectiveness to maintain competitiveness in the market.

Order Your Sample Copy of the Antimicrobial Additives Market Size, Share & Trends Analysis Report By Type (Organic, Inorganic), By Application (Plastics, Paints & Coatings, Pulp & Paper), By End-use, By Region, And Segment Forecasts, 2024 – 2030

Global Market Insights

The global antimicrobial additives market stood at USD 3.11 billion in 2023. This is expected to cross USD 5.60 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.0%. The industry is dominated by the Asia Pacific region, which accounted for over 38.0% share of the global revenue in 2023. The regional market is driven by the growth of major industries such as automotive, construction, healthcare, food and beverage, and packaging, among others. The robust manufacturing base of the automotive industry in countries such as China, India, and Japan is expected to boost the demand for antimicrobial additives in the near future.

The North American region also holds a significant share in the antimicrobial additives market due to stringent regulatory standards and high healthcare expenditure. At the same time, increasing consumer awareness regarding hygiene and growing demand in industries such as food processing and packaging are driving market growth in Europe.

Competitive Landscape and Future Outlook

The antimicrobial additives market is highly competitive, with several key players dominating the industry. Companies are focusing on research and development to introduce innovative antimicrobial technologies and expand their product portfolios. Strategic collaborations, mergers, and acquisitions are also prevalent strategies among market players to strengthen their market position. For example, BioCote Ltd. entered into a strategic partnership with Eco Finish in July 2023 to leverage the technology for antimicrobial surfaces in residential & commercial pools, delivering additional safety and protection for swimmers.

NanoBioMatters Industries S.L, RTP Company, BASF SE, Milliken Chemical, Microban International, BioCote Ltd., Clariant AG, Momentive Performance Materials Inc., Life Materials Technologies Ltd., PolyOne Corporation, SteriTouch Limited, Sanitized AG, LyondellBasell Industries Holdings B.V., Dow Inc., Plastics Color Corporation, and Lonza are some of the key companies operating in the global antimicrobial additives market.

The future of the antimicrobial additives industry looks promising with continued advancements in technology and increasing application across various industries. Key trends shaping the market include:

The development of sustainable antimicrobial solutions.
Integration of antimicrobial properties in smart textiles and wearable devices.
The expansion of antimicrobial additives into new application areas.

Although the market faces some challenges, such as environmental concerns and regulatory scrutiny, ongoing innovation and increasing awareness about infection control are expected to drive market growth. As global demand for antimicrobial protection continues to rise, stakeholders across industries are poised to capitalize on the expanding opportunities presented by this dynamic market.

Explore Horizon, the world’s most expansive market research database

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Endoscopes Market Driven by Growing Prevalence of Gastrointestinal, Respiratory, and Urological Disorders Requiring Early Detection

The global endoscopes market size is expected to reach USD 37.1 billion by 2030, registering a CAGR of 8.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing awareness levelsabout minimally invasive surgical procedures and the increasing prevalence of chronic disorders are the major factors accelerating the market growth. The benefits, such as less surgery-related blood loss, no muscle cutting, and quicker recovery, offered by minimally invasive surgeries boost the adoption of endoscopic procedures over traditional/open invasive surgeries. In addition, advancement in endoscopic technology and rapid increase of its application to diagnose and treat various diseases are other key factors anticipated to propel the market growth over the forecast years. The flexible endoscopes product segment dominated the market in 2023.

This is attributed to the high demand for these devices considering their unique features, such as the ability to reach viscera and cavities, better safety and efficiency, and improved ergonomic features. These devices are most commonly used in several endoscopic procedures, such as esophagogastroduodenoscopy (EGD), bronchoscopy, sigmoidoscopy, laryngoscopy, pharyngoscopy, nasopharyngoscopy, rhinoscopy, and colonoscopy procedures, which supports the product demand and segment growth.

Access the Endoscopes Market Size, Share & Trends Analysis Report 2024-2030, published by Grand View Research

In 2023, the outpatient facilities end-use segment dominated the market. Increasing adoption of endoscopes across outpatient facilities such as ambulatory surgery centers and diagnostic clinics for the early diagnosis and detection of several life-threatening diseases is supporting the segment growth. In addition, the introduction of keyhole endoscopic surgeries with minimal discomfort and faster recovery time also boosts the segment growth. In addition, North America held the largest revenue share in 2023 owing to its better healthcare infrastructure, high preference for minimally invasive surgical procedures among individuals, and quick adoption of advanced technologies. The increasing burden of functional gastrointestinal disorders and cancer is anticipated to further propel market growth in this region. For instance, as per the data reported by the National Cancer Institute, in 2020, over 1.8 million new cancer cases were estimated to be diagnosed in the U.S.

Several industry consolidation activities, such as mergers & acquisitions, and partnerships have resulted in a strong market share of the global market. Manufacturers in the market are also focusing on launching new endoscopes with advanced features as per patients’ requirements, to enhance their market share and consumer base. For instance, in January 2021, Karl Storz SE & Co. KG announced the launch of Image 1 S Rubina, which combines multimode fluorescence imaging with 4K resolution for endoscopy procedures. The toggling between white light and fluorescence modes allows surgeons to set it per surgical needs.

Order Your Sample Copy of the Endoscopes Market Size, Share & Trends Analysis Report By Product (Disposable, Flexible, Rigid), By End Use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2024 – 2030

Endoscopes Market Report Highlights

Based on product, the flexible endoscopes segment held the largest revenue share in 2023 owing to its unique features, such as the ability to reach viscera & cavities, better safety & efficiency, and improved ergonomic features

In terms of end-use, the outpatient facilities segment held the largest revenue share in 2023 due to widespread adoption of keyhole or minimal invasive surgeries across these facilities

North America dominated the market in 2023 owing to various factorsincluding the increasing burden of functional gastrointestinal disorders, improved healthcare infrastructure, and the growing preference for minimally invasive surgeries to curb healthcare spending.

Recent Developments

In November 2023, Olympus Corporation (Olympus), launched EVIS X1, its next-generation endoscopy system in China. This endoscopy system has been demonstrated at the 6th annual China International Import Expo that was held in Shanghai from November 5th -10th.

In March 2023, AIG Hospitals in Hyderabad launched a Center of Excellence (CoE) in collaboration with Boston Scientific. This collaboration aims to enhance healthcare services by providing advanced treatment options and expertise in various medical fields.

In January 2023, FUJIFILM India has launched FushKnife, a diathermic slitter and ClutchCutter, a rotatable forceps. The products were introduced at the 63rd Annual Conference of Indian Society of Gastroenterology-ISGCON in Jaipur.

Explore Horizon, the world’s most expansive market research database

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

IVF Services Demand Surges as Couples Seek Advanced Assisted Reproductive Technologies

The rising infertility among the male and female population across the globe is the primary driving factor for the growth of the in vitro fertilization market. Other main contributing factors to the growth of the market include rising reproductive tourism and the growing awareness among the population regarding in vitro fertilization. According to WHO, approximately 1 in 6 people(17.5% of the global population) worldwide – have infertility, which indicates a growing requirement for infertility treatments.

The change in lifestyle and increase in the average age of marrying, as well as an increase in the average age of conceiving a first child, is increasing globally. As the number of individuals opting for IVF treatments is growing, this trend is fueling the growth of in vitro fertilization treatments. In addition, many career-oriented women are opting for freezing their eggs and planning to have a child at a later stage in life. This growing reliance on fertility methods is anticipated to boost the IVF market. According to a Grand View Research report, the worldwide market for In vitro fertilization is projected to reach a value of USD 37.4 billion by the year 2030, at a compound annual growth rate of 5.54% over the forecast period of 2024 to 2030.

Access the In Vitro Fertilization Market Size, Share Trends Analysis Report 2024-2030, published by Grand View Research

As infertility is an issue that warrants both sensitivity and privacy, IVF service providers face the challenge of developing trust and authenticity through their digital platforms. Modern business requirements necessitate innovative methods of creating awareness about a particular cause or brand. Therefore, a virtual presence of all the entities involved (clinics, hospitals, and manufacturers) in the IVF process is recommended to create awareness about the treatments and their advantages to the individuals seeking this treatment.

Advantages of IVF Treatment

Genetic Testing Prior to IVF

The pre-implantation genetic testing (PGT) is a test that helps in identifying genetic disorders in embryos prior to their implantation in the IVF treatment. Couples who have a family history of certain disorders, unwanted traits, or genetic diseases can certainly overcome these disadvantages through the PGT as it helps them select an embryo that is free from genetic disorders, thus reducing the risk of passing the unwanted genetic trait to their offspring.

Pregnancy Time Management

Couples seeking IVF treatment other than infertility reasons can plan their pregnancy according to their preferred time through embryo or egg cryopreservation. Couples who were busy during their initial years of marriage or because of certain career commitments can definitely opt for IVF treatments as it has a high success rate and is certainly a beacon of hope for women over the age of 40 who suffer from a decline in age-related fertility.

Integration of Artificial Intelligence in IVF

In the past few years, the integration of time-lapse imaging and artificial intelligence (AI) into IVF procedures has demonstrated encouraging outcomes in enhancing the likelihood of success. Such technological progress has rendered IVF a more attainable and successful option for couples facing fertility challenges. For example, in May 2023, a collaboration between Genea Biomedx and AIVF introduced a cost-effective, personalized IVF treatment package. This comprehensive system combines the Geri time-lapse incubator from Genea Biomedx with the EMA AI platform developed by AIVF.

Order Your Sample Copy of the In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Equipment, Disposable Devices, Culture Media), By Procedure Type (Fresh Nondonor, Frozen Nondonor), By Providers, By Region, And Segment Forecasts, 2024 – 2030

Predictive Analytics:

AI algorithms can predict the success ratio for a specific IVF cycle by analyzing huge amounts of data, including genetic information, medical history, and hormonal levels. This can benefit both doctors and patients as AI can more effectively increase the probability of a successful pregnancy.

Back-to-Back IVF Cycles

The advantages of back-to-back IVF cycles are significant. Women opting for IVF can undertake several cycles back-to-back, bypassing the need to wait for the commencement of a menstrual cycle. This approach can be beneficial for couples eager to conceive promptly or for those who have urgent reasons to opt for IVF, including fertility reduction due to advancing age or health issues that could impact fertility.

Solution to Male Infertility

Intracytoplasmic Sperm Injection (ICSI) is a procedure that involves injecting a single sperm directly into an egg, offering a significant advantage for couples dealing with male infertility. Despite the ongoing debate about its advantages and disadvantages, it’s clear that ICSI can enhance fertilization prospects and boost IVF success rates for couples contending with male infertility, particularly when there are natural obstacles to sperm fertilizing the egg.

In Conclusion

As technology advances, IVF continues to evolve, promising greater success rates and making dreams of parenthood a reality for many. Its role in fertility preservation further gives hope to individuals, granting them autonomy over their reproductive choices. IVF is not just a treatment but a journey of hope, culminating in the joy of life’s most precious gift—a child.

Explore Horizon, the world’s most expansive market research database

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Industrial Air Filtration Market Evolving to Meet Stringent Emissions Regulations Worldwide

Rapid industrialization and rising environmental concerns are navigating the industrial air filtration market. The world is aware of its carbon footprints, and industries willingly focus on air filtration in their respective plants. Rising air pollution due to carbon and other pollutants such as pollutants such as nitrogen oxide, ammonia, and mercury are causing harm to the environment. Therefore, according to Grand View Research, the global industrial air filtration market is poised for significant growth, with an estimated size of around USD 7.43 billion in 2023 and a projected compound annual growth rate (CAGR) of 6.3% from 2024 to 2030.

Access the Industrial Air Filtration Market Size, Share & Trends Analysis Report 2024-2030, published by Grand View Research

Driving Factors of the Industrial Air Filtration Market

Multiple factors, such as international mandates like the UN Framework Convention on Climate Change, Montreal Protocol, Kyoto Protocol, COP24, and others, drive the market. In addition, respective countries’ government regulations increase workplace safety awareness and maintain high-quality air standards across various industries.

As the global economy continues to evolve, this market is expected to witness a surge in demand, particularly in key sectors such as cement, food and beverage, metal, power, pharmaceutical, manufacturing plants, chemical and petrochemical, paper and wood processing, and agriculture.

Benefits of Air Filtration in Industries

Reduces carbon emissions and helps to improve air quality
Effective in removing impure pollutants and contaminants
Increases the efficiency of workplaces by adhering to industry standards
Protect employees from hazardous air pollutants
Removes solid dust particles from polluted gases

The Types of Industrial Air Filtration Products
Industrial air filtration includes a diverse range of products, encompassing technologies and solutions. For example, cartridge collectors and filters, baghouse filters, mist collectors, fume collectors, and High-Efficiency Particulate Air (HEPA) filters are among the prominent product categories that cater to industrial facilities’ diverse needs.

Cartridge collectors and filters, for instance, offer efficient particulate removal, making them suitable for applications where fine dust and debris are a concern. On the other hand, baghouse filters excel in handling larger particulates, often found in cement, metal, and power generation industries.

Order Your Sample Copy of the Industrial Air Filtration Market Size, Share & Trends Analysis Report By Product, By End Use (Cement, Food & Beverage, Metal, Power, Pharmaceutical), By Region, And Segment Forecasts, 2024 – 2030

Mist collectors and fume collectors play a vital role in controlling airborne contaminants, such as oil mists and welding fumes, ensuring a safer working environment in manufacturing industries. HEPA filters, renowned for their exceptional filtration capabilities, are widely used in industries, such as pharmaceuticals and electronics manufacturing, where high-purity air is paramount.

As the market continues to evolve, industry players are actively investing in research and development to enhance the performance, energy efficiency, and sustainability of their filtration solutions. Advancements in materials, sensor technology, and data analytics are driving the industry forward, enabling more intelligent and adaptive air filtration systems.

Furthermore, the increasing emphasis on environmental sustainability and the reduction of greenhouse gas emissions have led to an increased adoption of energy-efficient and eco-friendly industrial air filtration systems. Manufacturers are exploring innovative technologies, such as renewable energy-powered units and advanced filtration media, to minimize the environmental impact of industrial operations.

Final word

An increasing focus on workplace safety and a growing concern for the environment is driving the market growth for industrial air filtration. This presents significant growth opportunities for manufacturers, service providers, and end-users across various industries. By staying abreast of the latest trends, making use of technological advancements, and adapting to the changing needs of diverse industries, stakeholders can stay competent in this expanding market.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/sector-reports-list

Advancements in Veterinary Imaging Instrument Sector: Trends and Opportunities from 2023 to 2030

Veterinary Imaging Instrument Industry | Forecast 2030

Grand View Research’s Veterinary Imaging Instrument industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

The global market size for the veterinary imaging instrument was estimated at USD 1.44 Billion in 2021 and is anticipated to increase at a CAGR of 5.7% from 2022 to 2030. The market is expected to expand because of the rising pet expenditure, the number of veterinarians in developed countries, and product launches. For instance, the helical fan beam CT system has enabled quicker scanning for routine imaging of the sinuses and teeth in horses, according to the Journal of the American Veterinary Medical Association in 2020. As a result of this quality, the helical fan beam CT system has been accepted by professionals and is currently in use.

Access the Global Veterinary Imaging Instrument Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies

Moreover, the rising prevalence of cardiovascular disease, arthritis, lameness, and the occurrence of bone injuries in pet population is further anticipated to fuel market growth. North America held the lion’s share in the regional market. However, competition in the emerging market is increasing because nations owe to demand from consumers’ end and veterinary infrastructure development.

Key veterinary imaging equipment manufacturers are adopting strategies such as JV, M&A etc that would provide a wider consumer base and geographic footprint. For instance, Zomedica Corp. highlighted a successful acquisition of Assisi’s LOOP and Calmer Canine product lines as well as assets of Revo2’s imaging products in its Q3 2022 report. The combination of these two product lines would give veterinarians the chance to better care for the animals they treat while also benefiting their clinics financially, ultimately resulting in an increase in business revenue as user adoption of the products rises.

Veterinary X-ray Market Insights

The global veterinary x-ray market size is estimated at USD 654.39 million in 2022 and is expected to grow at a lucrative compound annual growth rate (CAGR) of 6.31% over the forecast period. Demand for veterinary X-rays has increased due to a greater emphasis on animal health innovation, a greater need for diagnostics, increased pet adoption, and increased adoption of radiography in veterinary orthopedics, dentistry, and in several other indications. Furthermore, the increasing incidence of zoonotic diseases has increased the demand for effective diagnostic solutions, which is expected to drive global market growth. Moreover, technological advancements in X-ray diagnostics are further expected to boost adoption. For instance, in September 2022, SK Telecom from Korea launched an AI based diagnosis assistance X-ray service called X Caliber, capable of delivering quick analysis to the veterinarian.

Order your copy of the Free Sample of “Veterinary Imaging Instrument Industry Data Book – Veterinary X-Ray, Veterinary Ultrasound, Animal MRI and Animal/Veterinary CT Imaging Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030” Data Book, published by Grand View Research

The emergence of covid-19 had an impact on the entire healthcare sector, including veterinary medicine. The covid-19 was found to have slightly halted the growth of the market since several non-essential surgeries are restricted across the globe during the pandemic. Furthermore, strict restrictions on the transportation of individuals and goods led to a restricted patient influx in veterinary centers. Similarly, the shortage of skilled veterinarians, combined with suspended/postponed elective surgeries, significantly disrupted the activities of veterinary facilities, having a slightly negative impact on market providers.

Moreover, the pandemic has risen pet ownership in some countries, resulting in even more animal care delivery, which had increased the demand for veterinary diagnostic testing. For instance, the American Society for the Prevention of Cruelty to Animals (ASPCA) reported in May 2021 that one out of each five families had adopted a cat or dog since the early stages of the COVID-19 pandemic. Adoptions like these during the pandemic brought more attention to companion animal diagnosis and treatment. As a result, it is expected that it will boost the demand for the market during the forecast period.

Go through the table of content of Veterinary Imaging Instrument Industry Data Book to get a better understanding of the Coverage & Scope of the study

Veterinary MRI Market Insights

The global veterinary MRI market size was valued at USD 205.93 million in 2022 and is expected to expand at a lucrative compound annual growth rate (CAGR) of 7.38% from 2023 to 2030. The growth is primarily driven by the increasing pet humanization, technological advancements, initiatives by key companies, and the adoption of pet insurance. For instance, Time Medical Systems based in Hong Kong, offers 4 magnetic resonance imaging (MRI) scanners in the veterinary space namely, Panion Premie, Panion Pro, Panion, and Panion+. Panion for example is a dedicated open veterinary MRI machine that provides affordable diagnostic MR scans for pets.

The COVID-19 pandemic significantly impacted the market with supply chain challenges and dampened demand. However, it also led to increased awareness regarding animal health, an increase in vet visits, and concerns over zoonoses. The overall impact on the market was thus neutral and the sale of veterinary MRIs is anticipated to continue rising in the coming years. In March 2022 Hallmarq Veterinary Imaging, for instance, reported a key milestone of completing 300,000 animal scans using its MRI and CT machines.

Technological advancements are a key driver contributing to market growth. Companies are involved in the R&D of products, product launches, and upgrades to overcome challenges and increase their market share. For example, in November 2022, Hallmarq Veterinary Imaging launched a zero-helium small animal MRI machine in response to the shortage of helium supply, soaring helium prices, and enhanced sustainability. The new machine does not require helium or any additional power to cool the MRI magnet coils. It instead uses vacuum technology and a conduction-based cooling system.

Competitive Landscape

Key players operating in the veterinary imaging instrument market are IDEXX Laboratories, Inc.; Canon Medical Systems Corporation; FUJIFILM Holdings America Corporation, Samsung, Heska Corporation, and Butterfly Network, Inc. Some of the major private participants in the market are Carestream Health; Midmark Corporation; ESAOTE SPA, and SOUND. These players incorporate various strategic initiatives, such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches, to strengthen their market presence.

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/sector-reports-list